Table 3.
KAMUT® khorasan products consumption effects on absolute change of biochemical parameters
| Dependent variables (absolute change) | Parameter estimate, b | 95% CI |
|---|---|---|
| Fat mass, % | 3.70 | 1.56; 5.46 |
| BAP test, µmol Fe2+/l | − 102.28 | − 241.02; 118.98 |
| dROMs, U.carr | 28.88 | − 17.55; 60.09 |
| Arachidonic acid (AA) % | − 0.53 | − 1.05; 0.51 |
| Eicosapentaenoic acid (EPA) % | 0.13 | − 0.34; 0.23 |
| Docosahexaenoic acid (DHA) % | − 0.52 | − 1.08; − 0.12 |
| Total cholesterol, mg/dl | − 3.76 | − 10.25; 25.84 |
| LDL cholesterol, mg/dl | 4.04 | − 25.19; 14.06 |
| HDL cholesterol, mg/dl | 1.87 | − 6.01; 4.25 |
| Triglycerides, mg/dl | 14.80 | − 5.86; 24.17 |
| Homocysteine, µmol/l | 0.58 | − 1.47; 1.28 |
| Glycemia, mg/dl | 0.19 | − 1.94; 3.51 |
| Insulin, µU/ml | 2.38 | 0.19; 4.2 |
| Metabolism, Kcal | − 6.32 | − 62.5; 29.5 |
| AST, U/I | − 0.40 | − 3.8; 3.76 |
| ALT, U/I | 0.51 | − 4.45; 2.53 |
| Prot C, mg/dl | 0.01 | − 0.12; 0.05 |
Results of multiple quintile regression, adjusted for age, gender, physical activity and BMI
BAP biological antioxidant potential, ROM reactive oxygen metabolites, LDL low-density lipoprotein, HDL high-density lipoprotein, AST ASpartate aminoTransferase, ALT ALanine aminoTransferase, Prot C C-reactive protein